Page last updated: 2024-11-06

niludipin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

niludipin: bis(2-propoxyethyl) analog of nifedipine; structure; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID89767
CHEMBL ID2106840
SCHEMBL ID691639
MeSH IDM0071991

Synonyms (35)

Synonym
bay a 7168
niludipine [inn:ban]
bis(2-propoxyethyl) 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
niludipinum [inn-latin]
bay-a 7168
niludipin
einecs 245-120-6
nilupidine
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-, bis(2-propoxyethyl) ester
niludipina [inn-spanish]
bis(2-propoxyethyl) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, bis(2-propoxyethyl) ester
brn 0504197
bay a-7168
niludipine
22609-73-0
bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
niludipina
niludipinum
9844os3b0j ,
unii-9844os3b0j
CHEMBL2106840
FT-0630488
niludipine [inn]
niludipine [mart.]
SCHEMBL691639
VZWXXKDFACOXNT-UHFFFAOYSA-N
DB09240
J-014781
DTXSID20945267
Q7037475
(+/-)-niludipine; bay-a 7168
()-niludipine; bay-a 7168
3,5-pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, bis(2-propoxyethyl) ester
AKOS040753273

Research Excerpts

Overview

Niludipine is a potent calcium antagonistic coronary vasodilator with less cardiodepressant effect than nifedipine.

ExcerptReferenceRelevance
"Niludipine is a potent calcium antagonistic coronary vasodilator with less cardiodepressant effect than nifedipine."( Comparative coronary vasodilatory effects of nifedipine and niludipine.
Ito, T; Ogawa, K; Suzuki, T; Wakamasu, Y; Yamazaki, N, 1981
)
1.23

Compound-Compound Interactions

ExcerptReferenceRelevance
" The results indicate that niludipine, either alone or combined with propranolol and penfluzide, is effective in the treatment of patients with essential hypertension."( Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
Aoki, K; Sato, K, 1982
)
0.8

Bioavailability

ExcerptReferenceRelevance
" The influence of the Ca(2+) channel antagonists on pancreatic beta cell functions is dependent on lipophilicity, interactions with the cell membrane lipid bilayer, with SNAREs protein complexes in cell and vesicle membranes, with intracellular receptors, bioavailability and time of elimination from several organs and the bloodstream."( Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats.
Bisenieks, E; Briede, J; Duburs, G; Makarova, N; Poikāns, J; Stivriņa, M; Stoldere, D; Uldriķis, J,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (87.50)18.7374
1990's3 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (12.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (8.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]